Carbamazepine (Page 7 of 8)

HOW SUPPLIED

NDC:17856-4047-1 in a CUP of 10 SUSPENSIONS

[see USP Controlled Room Temperature]. Store Carbamazepine Tablets USP, (Chewable) at 20°C to 25°C (68°F to 77°F) Protect from light and moisture. Dispense in tight, light-resistant container (USP). Meets USP Dissolution Test 1.

White, round, flat beveled-edge, one side scored and engraved “TARO” above and “11” below the score, the other side plain. Carbamazepine Tablets USP, 200 mg:

Bottles of 100 NDC 51672-4005-1
Bottles of 500 NDC 51672-4005-2
Bottles of 1000 NDC 51672-4005-3

[see USP Controlled Room Temperature]. Store Carbamazepine Tablets USP at 20° to 25°C (68° to 77°F) Protect from moisture. Dispense in tight container (USP). Meets USP Dissolution Test 2.

White to off-white, round convex tablets embossed with “T91” on one side and plain on the other side. Carbamazepine Extended-Release Tablets USP, 100 mg:

Bottles of 30 NDC 51672-4123-6
Bottles of 100 NDC 51672-4123-1
Bottles of 1000 NDC 51672-4123-3

White to off-white, round convex tablets embossed with “T26” on one side and plain on the other side. Carbamazepine Extended-Release Tablets USP, 200 mg:

Bottles of 30 NDC 51672-4124-6
Bottles of 100 NDC 51672-4124-1
Bottles of 1000 NDC 51672-4124-3

White to off-white capsule-shaped tablets embossed with “T29” on one side and plain on the other. Carbamazepine Extended-Release Tablets USP, 400 mg:

Bottles of 30 NDC 51672-4125-6
Bottles of 100 NDC 51672-4125-1
Bottles of 1000 NDC 51672-4125-3

[see USP Controlled Room Temperature]. Store Carbamazepine Extended-Release Tablets USP at 20°C to 25°C (68°F to 77°F) Protect from moisture. Dispense in tight container (USP).

Orange colored and orange flavored suspension. Carbamazepine Oral Suspension USP, 100 mg/5 mL (teaspoonful):

Bottles of 450 mL NDC 51672-4047-9

Shake well before using.

[see USP Controlled Room Temperature]. Protect from freezing and from excessive heat. Store Carbamazepine Oral Suspension USP at 20°C to 25°C (68°F to 77°F) Dispense in tight, light-resistant container (USP).

Trademarks are the property of their respective owners.

Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761

Distributed by: , Hawthorne, NY 10532 Taro Pharmaceuticals U.S.A., Inc.

Revised: September 2015 70725-0915-9

MEDICATION GUIDE

Carbamazepine (kar” ba maz’ e peen) Tablets USP, Carbamazepine (kar” ba maz’ e peen) Oral Suspension USP, Carbamazepine (kar” ba maz’ e peen) Tablets USP (Chewable), and Carbamazepine (kar” ba maz’ e peen) Extended-Release Tablets USP

Read this Medication Guide before you start taking Carbamazepine Tablets USP, Carbamazepine Oral Suspension USP, Carbamazepine Tablets USP (Chewable), or Carbamazepine Extended-Release Tablets USP and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or treatment.

What is the most important information I should know about carbamazepine?

Do not stop taking carbamazepine without first talking to your healthcare provider.

Stopping carbamazepine suddenly can cause serious problems.

Carbamazepine can cause serious side effects, including:

1. Carbamazepine may cause rare but serious skin rashes that may lead to death. These serious skin reactions are more likely to happen when you begin taking carbamazepine within the first four months of treatment but may occur at later times. These reactions can happen in anyone, but are more likely in people of Asian descent. If you are of Asian descent, you may need a genetic blood test before you take carbamazepine to see if you are at a higher risk for serious skin reactions with this medicine. Symptoms may include:

  • skin rash
  • hives
  • sores in your mouth
  • blistering or peeling of the skin

2. Carbamazepine may cause rare but serious blood problems.

Symptoms may include:

  • fever, sore throat, or other infections that come and go or do not go away
  • easy bruising
  • red or purple spots on your body
  • bleeding gums or nose bleeds
  • severe fatigue or weakness

3. Like other antiepileptic drugs, carbamazepine may cause suicidal thoughts or actions in a very small number of people, about 1 in 500.

Call your healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you:

  • thoughts about suicide or dying
  • attempts to commit suicide
  • new or worse depression
  • new or worse anxiety
  • feeling agitated or restless
  • panic attacks
  • trouble sleeping (insomnia)
  • new or worse irritability
  • acting aggressive, being angry, or violent
  • acting on dangerous impulses
  • an extreme increase in activity and talking (mania)
  • other unusual changes in behavior or mood

How can I watch for early symptoms of suicidal thoughts and actions?

  • Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings.
  • Keep all follow-up visits with your healthcare provider as scheduled.

Call your healthcare provider between visits as needed, especially if you are worried about symptoms.

Do not stop carbamazepine without first talking to a healthcare provider.

Stopping carbamazepine suddenly can cause serious problems. You should talk to your healthcare provider before stopping.

Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare provider may check for other causes.

What is carbamazepine?

Carbamazepine is a prescription medicine used to treat:

  • certain types of seizures (partial, tonic-clonic, mixed)
  • certain types of nerve pain (trigeminal and glossopharyngeal neuralgia)

Carbamazepine is not a regular pain medicine and should not be used for aches or pains.

Who should not take carbamazepine?

Do not take carbamazepine if you:

  • have a history of bone marrow depression.
  • are allergic to carbamazepine or any of the ingredients in Carbamazepine Tablets USP, Carbamazepine Oral Suspension USP, Carbamazepine Tablets USP (Chewable), or Carbamazepine Extended-Release Tablets USP. See the end of this Medication Guide for a complete list of ingredients in Carbamazepine Tablets USP, Carbamazepine Oral Suspension USP, Carbamazepine Tablets USP (Chewable), or Carbamazepine Extended-Release Tablets USP.
  • take nefazodone.
  • are allergic to medicines called tricyclic antidepressants (TCAs). Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure.
  • have taken a medicine called a Monoamine Oxidase Inhibitor (MAOI) in the last 14 days. Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure.

What should I tell my healthcare provider before taking carbamazepine?

Before you take carbamazepine, tell your healthcare provider if you:

  • have or have had suicidal thoughts or actions, depression, or mood problems
  • have or ever had heart problems
  • have or ever had blood problems
  • have or ever had liver problems
  • have or ever had kidney problems
  • have or ever had allergic reactions to medicines
  • have or ever had increased pressure in your eye
  • have any other medical conditions
  • drink grapefruit juice or eat grapefruit
  • use birth control. Carbamazepine may make your birth control less effective. Tell your healthcare provider if your menstrual bleeding changes while you take birth control and carbamazepine.
  • are pregnant or plan to become pregnant. Carbamazepine may harm your unborn baby. Tell your healthcare provider right away if you become pregnant while taking carbamazepine. You and your healthcare provider should decide if you should take carbamazepine while you are pregnant.
    • If you become pregnant while taking carbamazepine, talk to your healthcare provider about registering with the North American Antiepileptic Drug (NAAED) Pregnancy Registry. The purpose of this registry is to collect information about the safety of antiepileptic medicine during pregnancy. You can enroll in this registry by calling 1-888-233-2334.
  • are breastfeeding or plan to breastfeed. Carbamazepine passes into breast milk. You and your healthcare provider should discuss whether you should take carbamazepine or breastfeed; you should not do both.

, including prescription and non-prescription medicines, vitamins, and herbal supplements. Tell your healthcare provider about all the medicines you take

Taking carbamazepine with certain other medicines may cause side effects or affect how well they work. Do not start or stop other medicines without talking to your healthcare provider.

Know the medicines you take. Keep a list of them and show it to your healthcare provider and pharmacist when you get a new medicine.

How should I take carbamazepine?

  • Do not stop taking carbamazepine without first talking to your healthcare provider. Stopping carbamazepine suddenly can cause serious problems. Stopping seizure medicine suddenly in a patient who has epilepsy may cause seizures that will not stop (status epilepticus).
  • Take carbamazepine exactly as prescribed. Your healthcare provider will tell you how much carbamazepine to take.
  • Your healthcare provider may change your dose. Do not change your dose of carbamazepine without talking to your healthcare provider.
  • Take carbamazepine with food.
  • Carbamazepine extended-release tablets:
    • Do not crush, chew, or break carbamazepine extended-release tablets.
    • Tell your healthcare provider if you can not swallow carbamazepine extended-release tablets whole.
  • Carbamazepine oral suspension:
    • Shake the bottle well each time before use.
    • Do not take carbamazepine oral suspension at the same time you take other liquid medicines.
  • If you take too much carbamazepine, call your healthcare provider or local Poison Control Center right away.

What should I avoid while taking carbamazepine?

  • Do not drink alcohol or take other drugs that make you sleepy or dizzy while taking carbamazepine until you talk to your healthcare provider. Carbamazepine taken with alcohol or drugs that cause sleepiness or dizziness may make your sleepiness or dizziness worse.
  • Do not drive, operate heavy machinery, or do other dangerous activities until you know how carbamazepine affects you. Carbamazepine may slow your thinking and motor skills.

What are the possible side effects of carbamazepine?

See ” ” ? What is the most important information I should know about carbamazepine

Carbamazepine may cause other serious side effects. These include:

  • Irregular heartbeat — symptoms include:
    • Fast, slow, or pounding heartbeat
    • Shortness of breath
    • Feeling lightheaded
    • Fainting
  • Liver problems — symptoms include:
    • yellowing of your skin or the whites of your eyes
    • dark urine
    • pain on the right side of your stomach area (abdominal pain)
    • easy bruising
    • loss of appetite
    • nausea or vomiting

Get medical help right away if you have any of the symptoms listed above or listed in “What is the most important information I should know about carbamazepine?”

The most common side effects of carbamazepine include:

  • dizziness
  • drowsiness
  • problems with walking and coordination (unsteadiness)
  • nausea
  • vomiting

These are not all the possible side effects of carbamazepine. For more information, ask your healthcare provider or pharmacist.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store carbamazepine?

  • Store Carbamazepine Tablets USP at 20°C to 25°C (68° to 77°F).
    • Keep Carbamazepine Tablets USP dry.
  • Store Carbamazepine Tablets USP (Chewable) at 20°C to 25°C (68° to 77°F).
    • Keep Carbamazepine Tablets USP (Chewable) out of the light.
    • Keep Carbamazepine Tablets USP (Chewable) dry.
  • Store Carbamazepine Extended-Release Tablets USP at 20°C to 25°C (68° to 77°F).
    • Keep Carbamazepine Extended-Release Tablets USP dry.
  • Store Carbamazepine Oral Suspension USP at 20°C to 25°C (68° to 77°F).
    • Shake well before using.
  • Keep Carbamazepine Oral Suspension USP in a tight, light-resistant container.

Keep carbamazepine and all medicines out of the reach of children.

General Information about carbamazepine

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use carbamazepine for a condition for which it was not prescribed. Do not give carbamazepine to other people, even if they have the same symptoms that you have. It may harm them.

This Medication Guide summarizes the most important information about carbamazepine. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for the full prescribing information about carbamazepine that is written for health professionals .

For more information call 1-866-923-4914.

What are the ingredients in carbamazepine?

Active ingredient: carbamazepine

Inactive ingredients:

  • – ammonio methacrylate copolymer, croscarmellose sodium, diethyl phthalate, FD&C red no. 40 lake, magnesium stearate, microcrystalline cellulose, natural cherry flavor, pregelatinized maize starch and sorbitol. Carbamazepine Tablets USP, (Chewable), 100 mg and 200 mg
  • – ammonio methacrylate copolymer, corn starch, croscarmellose sodium, diethyl phthalate, magnesium stearate and microcrystalline cellulose. Carbamazepine Tablets USP, 200 mg
  • – ammonio methacrylate copolymer, corn starch, diethyl phthalate, lactose monohydrate, magnesium stearate, microcrystalline cellulose and sodium starch glycolate. Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg
  • – citric acid monohydrate, FD&C yellow no. 6, orange flavor, poloxamer 188, potassium sorbate, propylene glycol, purified water, sorbitol solution, sucrose and xanthan gum. Carbamazepine Oral Suspension USP, 100 mg/5 mL

This Medication Guide has been approved by the U.S. Food and Drug Administration. Distributed by: , Hawthorne, NY 10532 Made in Israel
Taro Pharmaceuticals U.S.A., Inc.

Revised: September 2015 70725-0915-9

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.